FDA Sanctioned Lymphoseek To Help Determine Spread of Cancer in Head and Neck Region

June 14, 2014 10:39 AM

4 0

FDA Sanctioned Lymphoseek To Help Determine Spread of Cancer in Head and Neck Region

The federal regulators have approved a new injection, 'Lymphoseek', to determine the extent of spread of cancer in the head and neck.

Navidea's Lymphossek received the green signal from the U.S. Food and Drug Administration to help health care professionals determine the extent of the spread of squamous cell carcinoma in the head and neck region. Lymphoseek (technetium 99m tilmanocpet) injection is a radioactive diagnostic imagin...

Also read: Senate Clears Bill to Ease FDA Drug and Device Approvals

Read more

To category page

Loading...